Document is current
Any future updates will be listed below
-
Authors
Doskaliuk, Bohdana https://orcid.org/0000-0003-1650-8928
Ravichandran, Naveen https://orcid.org/0000-0003-2014-3925
Sen, Parikshit https://orcid.org/0000-0002-1630-6026
Day, Jessica https://orcid.org/0000-0001-8528-4361
Joshi, Mrudula https://orcid.org/0000-0001-7312-351X
Nune, Arvind https://orcid.org/0000-0002-3849-614X
Nikiphorou, Elena https://orcid.org/0000-0001-6847-3726
Saha, Sreoshy https://orcid.org/0000-0001-6745-9770
Tan, Ai Lyn https://orcid.org/0000-0002-9158-7243
Shinjo, Samuel Katsuyuki https://orcid.org/0000-0002-3682-4517
Ziade, Nelly https://orcid.org/0000-0002-4479-7678
Velikova, Tsvetelina https://orcid.org/0000-0002-0593-1272
Milchert, Marcin https://orcid.org/0000-0002-0943-8768
Jagtap, Kshitij https://orcid.org/0000-0003-2729-737X
Parodis, Ioannis https://orcid.org/0000-0002-4875-5395
Gracia-Ramos, Abraham Edgar https://orcid.org/0000-0003-1842-2554
Cavagna, Lorenzo https://orcid.org/0000-0003-3292-1528
Kuwana, Masataka https://orcid.org/0000-0001-8352-6136
Knitza, Johannes https://orcid.org/0000-0001-9695-0657
Chen, Yi Ming https://orcid.org/0000-0001-7593-3065
Makol, Ashima https://orcid.org/0000-0002-8748-898X
Agarwal, Vishwesh https://orcid.org/0000-0002-0986-8354
Patel, Aarat
Pauling, John D. https://orcid.org/0000-0002-2793-2364
Wincup, Chris https://orcid.org/0000-0002-8742-8311
Barman, Bhupen https://orcid.org/0000-0002-5433-1310
Tehozol, Erick Adrian Zamora https://orcid.org/0000-0002-7888-3961
Serrano, Jorge Rojas https://orcid.org/0000-0001-6980-7898
La Torre, Ignacio García-De https://orcid.org/0000-0002-9261-678X
Colunga-Pedraza, Iris J. https://orcid.org/0000-0002-2786-5843
Merayo-Chalico, Javier https://orcid.org/0000-0002-5870-0523
Chibuzo, Okwara Celestine https://orcid.org/0000-0002-7727-5657
Katchamart, Wanruchada https://orcid.org/0000-0002-8952-5967
Goo, Phonpen Akarawatcharangura https://orcid.org/0009-0009-7611-9992
Shumnalieva, Russka https://orcid.org/0000-0003-2321-6536
Hoff, Leonardo Santos https://orcid.org/0000-0002-2083-4796
Kibbi, Lina El https://orcid.org/0000-0003-1710-9996
Halabi, Hussein https://orcid.org/0000-0002-5174-8292
Vaidya, Binit https://orcid.org/0000-0002-4840-8924
Shaharir, Syahrul Sazliyana https://orcid.org/0000-0002-9068-8114
Hasan, A. T. M. Tanveer https://orcid.org/0000-0002-5332-3319
Dey, Dzifa https://orcid.org/0000-0002-3339-5112
Gutiérrez, Carlos Enrique Toro https://orcid.org/0000-0002-6084-7049
Caballero-Uribe, Carlo V. https://orcid.org/0000-0002-9845-8620
Lilleker, James B. https://orcid.org/0000-0002-9230-4137
Salim, Babur https://orcid.org/0000-0001-8430-9299
Gheita, Tamer https://orcid.org/0000-0002-1155-9729
Chatterjee, Tulika https://orcid.org/0000-0001-8844-851X
Distler, Oliver https://orcid.org/0000-0002-0546-8310
Saavedra, Miguel A. https://orcid.org/0000-0003-0687-9944
,
Kardes, Sinan
Andreoli, Laura
Lini, Daniele
Schreiber, Karen
Vince, Melinda Nagy
Singh, Yogesh Preet
Ranjan, Rajiv
Jain, Avinash
Pandya, Sapan C.
Pilania, Rakesh Kumar
Sharma, Aman
M, Manesh Manoj
Gupta, Vikas
Kavadichanda, Chengappa G.
Patro, Pradeepta Sekhar
Ajmani, Sajal
Phatak, Sanat
Goswami, Rudra Prosad
Chowdhury, Abhra Chandra
Mathew, Ashish Jacob
Shenoy, Padnamabha
Asranna, Ajay
Bommakanti, Keerthi Talari
Shukla, Anuj
Pande, Arunkumar R.
Chandwar, Kunal
Ghodke, Akanksha
Boro, Hiya
Fazal, Zoha Zahid
Cansu, Döndü Üsküdar
Yıldırım, Reşit
Del PapaSambataro, Armen Yuri Gasparyan Nicoletta Gian
Fabiola, Atzeni
Parisi, Marcello Govoni Simone
Bocci, Elena Bartoloni
Sebastiani, Gian Domenico
Fusaro, Enrico
Quartuccio, Marco Sebastiani Luca
Franceschini, Franco
Orsolini, Pier Paolo Sainaghi Giovanni
De AngelisVenerito, Rossella Maria Giovanna Danielli Vi
Grignaschi, Silvia
Giollo, Alessandro
Alluno, Alessia
Ioannone, Florenzo
Fornaro, Marco
Traboco, Lisa S.
Wibowo, Suryo Anggoro Kusumo
Loarce-Martos, Jesús
Prieto-González, Sergio
Gonzalez, Raquel Aranega
Yoshida, Akira
Nakashima, Ran
Sato, Shinji
Kimura, Naoki
Kaneko, Yuko
Gono, Takahisa
Tomaras, Stylianos
Proft, Fabian Nikolai
Holzer, Marie-Therese
Gromova, Margarita Aleksandrovna
Aharonov, Or
Griger, Zoltán
Hmamouchi, Ihsane
bouchti, Imane El
Baba, Zineb
Giannini, Margherita
Maurier, François
Campagne, Julien
Meyer, Alain
Langguth, Daman
Limaye, Vidya
Needham, Merrilee
Srivastav, Nilesh
Landon-Cardinal, Marie Hudson Océane
Zuleta, Wilmer Gerardo Rojas
Cajas, Álvaro Arbeláez Javier
Silva, José António Pereira
Fonseca, João Eurico
Bohdana, Olena Zimba Doskaliuk
Ima-Edomwonyi, Uyi
Dedeke, Ibukunoluwa
Airenakho, Emorinken
Madu, Nwankwo Henry
Yerima, Abubakar
Olaosebikan, Hakeem
A., Becky
Koussougbo, Oruma Devi
Palalane, Elisa
So, Ho
Ugarte-Gil, Manuel Francisco
Chinchay, Lyn
Bernaola, José Proaño
Pimentel, Victorio
Fathi, Hanan Mohammed
Mohammed, Reem Hamdy A.
Harifi, Ghita
Cabriza, Yurilís Fuentes-Silva Karoll
Losanto, Jonathan
Colaman, Nelly
Cachafeiro-Vilar, Antonio
Bautista, Generoso Guerra
Ho, Enrique Julio Giraldo
Nunez, Lilith Stange
M, Cristian Vergara
Báez, Jossiell Then
Alonzo, Hugo
Pastelin, Carlos Benito Santiago
Salinas, Rodrigo García
Obiols, Alejandro Quiñónez
Chávez, Nilmo
Ordóñez, Andrea Bran
Llerena, Gil Alberto Reyes
Sierra-Zorita, Radames
Arrieta, Dina
Hidalgo, Eduardo Romero
Saenz, Ricardo
M, Idania Escalante
Calapaqui, Wendy
Quezada, Ivonne
Arredondo, Gabriela
Chinoy, Hector https://orcid.org/0000-0001-6492-1288
Agarwal, Vikas https://orcid.org/0000-0002-4508-1233
Aggarwal, Rohit https://orcid.org/0000-0001-7531-8038
Gupta, Latika https://orcid.org/0000-0003-2753-2990
- License Information
-
More Information
Article History
Received: 18 April 2023
Accepted: 10 May 2023
First Online: 23 June 2023
Declarations
:
: ALT has received honoraria for advisory boards and speaking for Abbvie, Gilead, Janssen, Lilly, Novartis, Pfizer, and UCB. EN has received speaker honoraria/participated in advisory boards for Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie, and Lilly, and holds research grants from Pfizer and Lilly. HC has received grant support from Eli Lilly and UCB, consulting fees from Novartis, Eli Lilly, Orphazyme, Astra Zeneca, speaker for UCB, and Biogen. IP has received research funding and/or honoraria from Amgen, AstraZeneca, Aurinia Pharmaceuticals, Elli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis and F. Hoffmann-La Roche AG. JBL has received speaker honoraria/participated in advisory boards for Sanofi Genzyme, Roche, and Biogen. None is related to this manuscript. JD has received research funding from CSL Limited. JDP has undertaken consultancy work and/or received speaker honoraria from Astra Zenaca, Boehringer Ingelgheim, Sojournix Pharma, Permeatus Inc, Janssen and IsoMab Pharmacueticals. MK has received speaker honoraria/participated in advisory boards for Abbvie, Asahi-Kasei, Astellas, AstraZeneca, Boehringer-Ingelheim, Chugai, Corbus, Eisai, GSK, Horizon, Kissei, BML, Mochida, Nippon Shinyaku, Ono Pharmaceuticals, Tanabe-Mitsubishi. NZ has received speaker fees, advisory board fees, and research grants from Pfizer, Roche, Abbvie, Eli Lilly, NewBridge, Sanofi-Aventis, Boehringer Ingelheim, Janssen, and Pierre Fabre; none are related to this manuscript. OD has/had consultancy relationship with and/or has received research funding from and/or has served as a speaker for the following companies in the area of potential treatments for systemic sclerosis and its complications in the last 3 calendar years: 4P-Pharma, Abbvie, Acceleron, Alcimed, Altavant, Amgen, AnaMar, Arxx, AstraZeneca, Baecon, Blade, Bayer, Boehringer Ingelheim, Corbus, CSL Behring, Galderma, Galapagos, Glenmark, Gossamer, iQvia, Horizon, Inventiva, Janssen, Kymera, Lupin, Medscape, Merck, Miltenyi Biotec, Mitsubishi Tanabe, Novartis, Prometheus, Redxpharma, Roivant, Sanofi and Topadur. Patent issued “mir-29 for the treatment of systemic sclerosis” (US8247389, EP2331143). RA has a consultancy relationship with and/or has received research funding from the following companies: Bristol Myers-Squibb, Pfizer, Genentech, Octapharma, CSL Behring, Mallinckrodt, AstraZeneca, Corbus, Kezar, Abbvie, Janssen, Kyverna Alexion, Argenx, Q32, EMD-Serono, Boehringer Ingelheim, Roivant, Merck, Galapagos, Actigraph, Scipher, Horizon Therepeutics, Teva, Beigene, ANI Pharmaceuticals, Biogen, Nuvig, Capella Bioscience, and CabalettaBio. TV has received speaker honoraria from Pfizer and AstraZeneca, non-related to the current manuscript. Rest of the authors have no conflict of interest relevant to this manuscript.
: Ethical approval was obtained from the Institutional Ethics Committee of the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow, 226014. HC was supported by the National Institution for Health Research Manchester Biomedical Research Centre Funding Scheme. The views expressed in this publication are those of the authors and not necessarily those of the NHS, National Institute for Health Research, or Department of Health.
: No part of this manuscript has been copied or published elsewhere either in whole or in part.
